10-K: Qrons Inc. Secures $250,000 in Convertible Debt Financing to Fuel Cognitive Wellness Expansion

Qrons Inc. enters into a series of note purchase agreements to secure $250,000 in convertible debt financing, aimed at supporting general working capital and expanding its cognitive wellness business.

Summary

• Qrons Inc. has entered into a series of note purchase agreements to raise up to $350,000, with an initial closing of $50,000 from Quick Capital, LLC.
• The company issued a secured convertible promissory note with a face value of $55,555.56 to Quick Capital, reflecting a 10% original issuance discount, bearing interest at 12% per annum and maturing in nine months.
• The note is convertible into common stock at a fixed conversion price of $0.02, subject to certain adjustments.
• As part of the agreement, Qrons issued 315,000 commitment shares and a warrant to purchase 1,111,111 shares of common stock at an exercise price of $0.05 per share to Quick Capital.
• The company also entered into similar agreements with Cory Rosenberg, BC Funds, LLC and Leonite Fund I, LP for additional financing.
• The proceeds from the sale of the notes will be used for general working capital, including the completion of the 2023 audit of First Person Ltd., legal and accounting expenses, and OTC Markets fees.
• The agreements include covenants such as piggyback registration rights, restrictions on variable rate transactions, and participation rights in future offerings.

Sentiment

Score: 7

Explanation: The document outlines a financing agreement, which is generally positive as it provides the company with capital. However, the high interest rate and potential dilution are concerns, resulting in a neutral to slightly positive sentiment.

Positives

• The financing provides Qrons with additional capital to support its operations and growth initiatives.
• The convertible nature of the notes offers flexibility for both the company and the investors.
• The inclusion of warrants provides investors with potential upside from future stock appreciation.
• The agreements include covenants designed to protect the investors interests.

Negatives

• The notes bear interest at 12% per annum, which could increase the company's debt burden.
• The conversion of the notes and exercise of warrants could dilute existing shareholders equity.
• The agreements include restrictions on certain transactions, which could limit the company's flexibility.
• The company is required to maintain a reserve of shares for conversion, which could limit its ability to raise capital in the future.

Risks

• The company's ability to repay the notes or generate sufficient cash flow to service the debt is uncertain.
• The conversion of the notes and exercise of warrants could dilute existing shareholders equity.
• The company's business plan may not be successful, and it may not be able to generate sufficient revenue to support its operations.
• The company is subject to various risks and uncertainties, including those related to its industry, competition, and regulatory environment.

Future Outlook

The company intends to use the proceeds from the sale of the notes for general working capital and to expand its cognitive wellness business.

Industry Context

The financing reflects a trend of companies seeking capital to fund growth in the cognitive wellness and functional beverage markets.

Stakeholder Impact

• Shareholders may experience dilution from the conversion of the notes and exercise of warrants.
• The company's employees and customers may benefit from the additional capital and expansion of the business.
• The company's suppliers and creditors may benefit from the company's improved financial position.

Next Steps

• The company will use the proceeds from the sale of the notes for general working capital and to expand its cognitive wellness business.
• The company will file all required reports with the SEC.
• The company will work to secure the listing of the conversion shares and warrant shares on a national securities exchange or automated quotation system.
• The company will comply with the reporting requirements of the Exchange Act.

Key Dates

Keywords

convertible note, warrant, financing, common stock, Qrons Inc, note purchase agreement, cognitive wellness, capital raise, securities, investment